FDA Brief

Warning letters Biologics

FDA warning letter to

Abbott Laboratories

Issued Oct 24, 2023Posted Oct 25, 2023Center for Biologics Evaluation and Research (CBER)

Dietary Supplement/Adulterated. We haven't summarized this letter yet. Read it on fda.gov.

Abbott Laboratories's FDA history

Recalls in the last 12 months

Dec 24, 2025 Class II Abbott Laboratories
Device
Alinity ci-series System Control Module (SCM), REF: 03R70-01, 03R70-20
Abbott Laboratories is recalling their Alinity ci-series System Control Module, a chemistry/immunoassay anayzer, by correction. The reason for the recall is potential performance issues found in the Alinity ci-series System software versions 3.6.1. and lower that could lead to erroneous results for multiple analytes. The issue was identified by Abbott during the internal testing of complaint investigations.
Nov 19, 2025 Class II Abbott Laboratories
Device
Brand Name: Alinity hq Analyzer Product Name: Alinity hq Analyzer Model/Catalog Number: 09P68-01 Software Version: 5.0 to 5.10.1 for OUS, 5.7 and 5.10.1 in the US Product Description: Alinity hq Analyzer Component: …
Software issue for hq analyzer results in system not visibly applying appropriate flagging to results when saturation is present which may result in incorrect results.

Full company page